| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Screening Assays | 2 | 2018 | 216 | 1.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 503 | 0.590 |
Why?
|
| RNA, Small Interfering | 8 | 2020 | 2216 | 0.550 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 598 | 0.470 |
Why?
|
| Nitriles | 4 | 2020 | 906 | 0.470 |
Why?
|
| RNA Interference | 3 | 2019 | 1408 | 0.450 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2018 | 509 | 0.440 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 3821 | 0.440 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2011 | 16 | 0.420 |
Why?
|
| Pyridines | 3 | 2011 | 1244 | 0.370 |
Why?
|
| Ovarian Neoplasms | 7 | 2020 | 4638 | 0.350 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2006 | 323 | 0.340 |
Why?
|
| Phosphofructokinase-2 | 2 | 2019 | 38 | 0.320 |
Why?
|
| Paclitaxel | 5 | 2019 | 1996 | 0.300 |
Why?
|
| Cell Line, Tumor | 19 | 2021 | 14551 | 0.280 |
Why?
|
| Apoptosis | 6 | 2018 | 7591 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2020 | 5178 | 0.260 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2011 | 1094 | 0.260 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 589 | 0.240 |
Why?
|
| Microtubules | 2 | 2018 | 270 | 0.240 |
Why?
|
| Blast Crisis | 1 | 2007 | 557 | 0.230 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2020 | 177 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 810 | 0.210 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2023 | 1215 | 0.210 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 984 | 0.210 |
Why?
|
| Schizosaccharomyces pombe Proteins | 4 | 2003 | 84 | 0.190 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 598 | 0.190 |
Why?
|
| Schizosaccharomyces | 4 | 2003 | 116 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1493 | 0.170 |
Why?
|
| Antineoplastic Agents | 4 | 2018 | 14289 | 0.170 |
Why?
|
| Cyanoacrylates | 3 | 2011 | 41 | 0.170 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2011 | 2527 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 10331 | 0.170 |
Why?
|
| Mice | 14 | 2023 | 34495 | 0.170 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 621 | 0.160 |
Why?
|
| Shiga Toxin 2 | 1 | 2017 | 3 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2018 | 852 | 0.160 |
Why?
|
| Phenalenes | 1 | 2017 | 1 | 0.160 |
Why?
|
| Cryptococcus neoformans | 1 | 2017 | 27 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 3 | 2020 | 1121 | 0.150 |
Why?
|
| HeLa Cells | 4 | 2017 | 1643 | 0.150 |
Why?
|
| Ascomycota | 1 | 2017 | 31 | 0.150 |
Why?
|
| Benzophenones | 1 | 2017 | 12 | 0.150 |
Why?
|
| Diterpenes | 1 | 2017 | 111 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2020 | 2488 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2016 | 17 | 0.150 |
Why?
|
| Animals | 18 | 2023 | 59536 | 0.150 |
Why?
|
| Spiro Compounds | 1 | 2017 | 58 | 0.150 |
Why?
|
| E2F Transcription Factors | 1 | 2016 | 132 | 0.140 |
Why?
|
| Aspergillus | 1 | 2017 | 149 | 0.140 |
Why?
|
| Karyopherins | 3 | 2006 | 136 | 0.140 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 139 | 0.140 |
Why?
|
| Triterpenes | 1 | 2016 | 61 | 0.140 |
Why?
|
| beta Karyopherins | 2 | 2006 | 36 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 5395 | 0.140 |
Why?
|
| Glutaminase | 1 | 2016 | 47 | 0.140 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 60 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 905 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 4757 | 0.130 |
Why?
|
| Fungi | 1 | 2017 | 145 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 973 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 278 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 34 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 534 | 0.130 |
Why?
|
| Anoikis | 1 | 2015 | 63 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 335 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 222 | 0.130 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2018 | 436 | 0.130 |
Why?
|
| Transfection | 3 | 2016 | 2944 | 0.130 |
Why?
|
| Cell Death | 1 | 2017 | 671 | 0.120 |
Why?
|
| beta Catenin | 2 | 2016 | 688 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2023 | 4307 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2018 | 874 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2018 | 1869 | 0.120 |
Why?
|
| Signal Transduction | 8 | 2020 | 11965 | 0.120 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2013 | 15 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2018 | 2450 | 0.120 |
Why?
|
| Auranofin | 1 | 2013 | 38 | 0.110 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2006 | 591 | 0.110 |
Why?
|
| Cell Proliferation | 7 | 2023 | 7226 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 2054 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 1399 | 0.110 |
Why?
|
| Humans | 33 | 2023 | 261506 | 0.110 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 146 | 0.110 |
Why?
|
| Hexanones | 1 | 2012 | 10 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 4821 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2014 | 269 | 0.100 |
Why?
|
| Primary Myelofibrosis | 1 | 2020 | 831 | 0.100 |
Why?
|
| Equipment and Supplies | 1 | 2011 | 48 | 0.100 |
Why?
|
| Cell Nucleus | 3 | 2005 | 1620 | 0.100 |
Why?
|
| Cytotoxins | 1 | 2011 | 66 | 0.100 |
Why?
|
| Tubulin Modulators | 1 | 2011 | 65 | 0.100 |
Why?
|
| Computer Security | 1 | 2011 | 41 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2017 | 834 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 376 | 0.100 |
Why?
|
| Cell Survival | 5 | 2020 | 3045 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2018 | 1077 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 566 | 0.090 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 424 | 0.090 |
Why?
|
| Sarcoma, Ewing | 1 | 2014 | 406 | 0.090 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 93 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 95 | 0.090 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 204 | 0.090 |
Why?
|
| Cell Communication | 1 | 2013 | 509 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 3 | 2005 | 2518 | 0.090 |
Why?
|
| Melanoma | 1 | 2007 | 5317 | 0.090 |
Why?
|
| Phosphorylation | 8 | 2018 | 4804 | 0.090 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2011 | 216 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2020 | 2947 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 2265 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 5159 | 0.080 |
Why?
|
| Trans-Activators | 2 | 2005 | 1555 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 1648 | 0.080 |
Why?
|
| Gene Silencing | 3 | 2019 | 837 | 0.080 |
Why?
|
| Methyltransferases | 2 | 2001 | 148 | 0.080 |
Why?
|
| Endocytosis | 2 | 2006 | 225 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2017 | 2819 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2011 | 575 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2007 | 1764 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 1265 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2017 | 71 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5319 | 0.070 |
Why?
|
| Peptide Mapping | 1 | 2007 | 114 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2006 | 2295 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3552 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 8873 | 0.070 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2007 | 231 | 0.070 |
Why?
|
| Imatinib Mesylate | 2 | 2011 | 1665 | 0.070 |
Why?
|
| Cell Cycle | 3 | 2019 | 2084 | 0.070 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 10 | 0.070 |
Why?
|
| Endosomes | 3 | 2017 | 109 | 0.070 |
Why?
|
| Breast Neoplasms | 6 | 2019 | 15694 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2005 | 27 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 987 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2017 | 515 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2006 | 94 | 0.070 |
Why?
|
| Benzamides | 2 | 2011 | 1832 | 0.070 |
Why?
|
| Female | 12 | 2020 | 141928 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2013 | 5061 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 161 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 264 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 314 | 0.060 |
Why?
|
| Point Mutation | 1 | 2007 | 769 | 0.060 |
Why?
|
| Pyrimidines | 3 | 2020 | 3518 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 215 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2007 | 560 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 703 | 0.060 |
Why?
|
| Leucine Zippers | 1 | 2023 | 39 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1487 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 750 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 460 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 492 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 1062 | 0.060 |
Why?
|
| Mutation | 5 | 2020 | 15179 | 0.050 |
Why?
|
| Protein Transport | 2 | 2017 | 734 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 614 | 0.050 |
Why?
|
| Autophagy | 2 | 2020 | 927 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 7222 | 0.050 |
Why?
|
| Piperazines | 2 | 2011 | 2101 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 862 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2576 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2007 | 2074 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2017 | 3536 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2001 | 2022 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2005 | 644 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 3578 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2015 | 5270 | 0.050 |
Why?
|
| Cell Movement | 2 | 2021 | 2466 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 5637 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1070 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 889 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 64 | 0.050 |
Why?
|
| Transcriptome | 2 | 2020 | 1859 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 124 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 159 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2021 | 519 | 0.040 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2020 | 63 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 1999 | 254 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2020 | 174 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1998 | 108 | 0.040 |
Why?
|
| Shiga Toxin 1 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 733 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2018 | 182 | 0.040 |
Why?
|
| Neoplasms | 2 | 2016 | 15193 | 0.040 |
Why?
|
| Hyraxes | 1 | 2017 | 1 | 0.040 |
Why?
|
| Namibia | 1 | 2017 | 1 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 336 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 668 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 769 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 334 | 0.040 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2016 | 13 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 255 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2017 | 147 | 0.040 |
Why?
|
| Models, Biological | 3 | 2014 | 3254 | 0.040 |
Why?
|
| Nuclear Localization Signals | 2 | 2006 | 46 | 0.040 |
Why?
|
| p21-Activated Kinases | 3 | 2003 | 122 | 0.030 |
Why?
|
| Candida albicans | 1 | 2017 | 175 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 11538 | 0.030 |
Why?
|
| Mitosis | 1 | 1998 | 615 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 117 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2018 | 309 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 611 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2018 | 387 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 627 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 2138 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 3570 | 0.030 |
Why?
|
| CHO Cells | 2 | 2006 | 311 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 370 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 7548 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 137 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2003 | 997 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 348 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 347 | 0.030 |
Why?
|
| Cricetinae | 2 | 2006 | 706 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 6150 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 661 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 994 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 1090 | 0.030 |
Why?
|
| Mustard Compounds | 1 | 2013 | 8 | 0.030 |
Why?
|
| Base Sequence | 3 | 2005 | 4917 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2013 | 19 | 0.030 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2013 | 104 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2013 | 120 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 2027 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 260 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 584 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 767 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 1466 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2012 | 8 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 328 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 445 | 0.030 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 167 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 249 | 0.020 |
Why?
|
| RNA | 1 | 2016 | 1013 | 0.020 |
Why?
|
| Protein Binding | 3 | 2005 | 3438 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2012 | 171 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 554 | 0.020 |
Why?
|
| Glutathione | 1 | 2013 | 368 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1471 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1165 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 3203 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 2045 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 4233 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 2809 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 3033 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2016 | 9180 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 21713 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 717 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2016 | 992 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 549 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2437 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 6089 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2011 | 220 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 1213 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 825 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 4557 | 0.020 |
Why?
|
| Binding Sites | 2 | 2005 | 2171 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1082 | 0.020 |
Why?
|
| DNA | 1 | 2016 | 2693 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 3101 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 1073 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 3639 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2014 | 1154 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.020 |
Why?
|
| Clathrin | 1 | 2005 | 34 | 0.020 |
Why?
|
| ran GTP-Binding Protein | 1 | 2005 | 34 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 16 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 40 | 0.020 |
Why?
|
| Genes, bcl-1 | 1 | 2005 | 24 | 0.020 |
Why?
|
| Genes, fos | 1 | 2005 | 53 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2005 | 64 | 0.020 |
Why?
|
| Cricetulus | 1 | 2005 | 205 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 10035 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 392 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2005 | 229 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 261 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 518 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 5767 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 423 | 0.010 |
Why?
|
| United States | 1 | 2020 | 15433 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 630 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 483 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2005 | 1313 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2001 | 47 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 1399 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2005 | 679 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 120 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2000 | 329 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 319 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 1999 | 4 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3230 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 331 | 0.010 |
Why?
|
| Serine | 1 | 2000 | 388 | 0.010 |
Why?
|
| Morpholines | 1 | 2000 | 289 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 798 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 1442 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 13658 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 1756 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 844 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 2489 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1471 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 1555 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 1879 | 0.010 |
Why?
|
| Child | 1 | 2014 | 29154 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 5114 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 6086 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 37905 | 0.010 |
Why?
|
| Male | 1 | 2000 | 123000 | 0.000 |
Why?
|